Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir-Reference-Cited by-同舟云学术

Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir

Published:2018-04 Issue:4 Volume:16 Page:567-574.e6
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Younossi Zobair M.,Stepanova Maria,Gordon Stuart,Zeuzem Stefan,Mann Michael P.,Jacobson Ira,Bourliere Marc,Cooper Curtis,Flamm Steven,Reddy K. Rajender,Kowdley Kris,Younossi Issah,Hunt Sharon

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference43 articles.

1. The impact of hepatitis C burden: an evidence-based approach;Younossi;Aliment Pharmacol Ther,2014

2. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013;Beste;Gastroenterology,2015

3. Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden;Younossi;Gastroenterology,2016

4. A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection;Park;J Viral Hepat,2015

5. Rising mortality associated with hepatitis C virus in the United States, 2003-2013;Ly;Clin Infect Dis,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe impairment of patient‐reported outcomes in patients with chronic hepatitis C virus infection seen in real‐world practices across the world: Data from the global liver registry;Journal of Viral Hepatitis;2022-09-07

3. Successful Eradication of Hepatitis-C Virus with Sofosbuvir based Antiviral treatment results in improvement in quality of life in cirrhotic patients;Pakistan Journal of Medical Sciences;2022-03-05

4. Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis;Internal Medicine;2021-03-01

5. Hepatitis C direct‐acting antiviral outcomes in patients 75 years and older;JGH Open;2020-12-18